Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates [Yahoo! Finance]
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Profit Outlook [Yahoo! Finance]